D-0725-2016 Class III Terminated
FDA drug recall D-0725-2016 was initiated by Zydus Pharmaceuticals USA Inc on Jan 14, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of specification for a known degradant. The recall status is terminated (terminated Dec 18, 2020). Affected quantity: 9504 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 2, 2016
- Initiation Date
- Jan 14, 2016
- Termination Date
- Dec 18, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9504 Bottles
Product description
risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC: 68382-156-06.
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification for a known degradant.
Distribution pattern
US Nationwide including Puerto Rico
Code information
Lot #: MP4967, Expiry: 04/2016.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0725-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026